DCT

1:14-cv-00422

Reckitt Benckiser Pharma Inc v. Par Pharmaceutical Inc

General

Filed

04/04/14

Cause of ActionInfringement

SectorBiotech

Status

Closed (09/28/17)

Patent Owner

NPE (W)

PACER1:14-cv-00422

Appeals17-2587

CourtD. Delaware

Judge	Period	PO Win Rate
Richard G. Andrews	--	27%

Plaintiff

Party

Name	Ratings
Reckitt Benckiser PLC	L2E
Reckitt Benckiser LLC	L2E
RB Pharmaceuticals Ltd	L1D
MonoSol RX LLC NPE	L1E

Attorney

Name	Ratings
Womble Bond Dickinson US LLP	L5A
Mary W. Bourke	L5A
Dana K. Severance	L4D
Troutman Sanders LLP	L5A
Daniel A. Ladow	L5C
James M. Bollinger	L5E
Timothy P. Heaton	L4B
J. Magnus Essunger	L4D
Troy S. Kleckley	L1C
Steptoe & Johnson LLP	L3E
Timothy C. Bickham	L5E
James F. Hibey	L4C

Defendant

Party

Name	Ratings
Par Pharmaceutical Inc	L5E
IntelGenx Technologies Corp	L1C
IntelGenx Corp	L1C

Attorney

Name	Ratings
Richards Layton & Finger PALocal	L5E
Steven J. Fineman	L5D
Katharine L. Mowery	L5E
Latham & Watkins LLP	L4A
Daniel G. Brown	L5D
Jennifer Koh	L5D
Emily C. Melvin	L3D
Michelle R. Ma	L3D
James K. Lynch	---- --